The Art of Nanoimmunobiotechnomedicine in Depression Management

Nanoimmunobiotechnomedicine represents a frontier for personalized depression therapies. The integration of nanotechnology and immunobiology enhances bioavailability and specificity in targeting depressive disorders at the molecular level. This convergence of molecular biology, and bioinformatics studies holds significant potential to revolutionize depression treatment, offering more effective and individualized solutions for better mental health outcomes.

Authors

Institutions

Publication Details

Journal
Advanced Pharmaceutical Bulletin
Published
2025-10-18
DOI
https://doi.org/10.34172/apb.025.42757
Primary Topic
Tryptophan and brain disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Art of Nanoimmunobiotechnomedicine in Depression Management

Suryani As’ád, Novi Sekar Sari, Novi Irmania, Dito Anurogo et al.
Advanced Pharmaceutical Bulletin
Tryptophan and brain disorders
article

The Art of Nanoimmunobiotechnomedicine in Depression Management

Suryani As’ád, Novi Sekar Sari, Novi Irmania, Dito Anurogo, Noorman Rinanto, Nur Rahmah Awaliah, Ami Febriza, Maulida Mazaya, Nguyen Quoc Khanh Le, Riswal Nafi Siregar, Kholis Abdurachim Audah, Gangga Anuraga, Maratu Soleha, Arli Aditya Parikesit, Era Catur Prasetya, Tzu‐Jen Kao, Ahmad Hafidul Ahkam, Azzah Khoridah Maulidiya, Amir Su'udi, Muhammad Sobri Maulana, Andi Weri Sompa, Riri Rimbun Anggih Chaidir, Waode Fifin Ervina, Ririn Tri Ratnasari, Tria Astika Endah Permatasari, Nadhirah Nordin
article en

Abstract

Nanoimmunobiotechnomedicine represents a frontier for personalized depression therapies. The integration of nanotechnology and immunobiology enhances bioavailability and specificity in targeting depressive disorders at the molecular level. This convergence of molecular biology, and bioinformatics studies holds significant potential to revolutionize depression treatment, offering more effective and individualized solutions for better mental health outcomes.

Advanced Pharmaceutical BulletinVol. 15(4)
State University of Semarang (ID), National Taiwan University of Science and Technology (TW), Universitas Airlangga (ID), Universitas Negeri Surabaya (ID), Muhammadiyah University of Makassar (ID), State University of Jakarta (ID), Universitas Esa Unggul (ID), Klinik und Poliklinik für Psychosomatik und Psychotherapie (DE), Institut Pertanian Malang (ID), Universitas Patria Artha (ID), Sumatera Institute of Technology (ID), Universitas Muhammadiyah Jakarta (ID), Indonesia International Institute for Life Sciences (ID), Universitas Pamulang (ID), Universitas 45 Surabaya (ID), National Nuclear Energy Agency of Indonesia (ID), Universitas Muhammadiyah Surabaya (ID), National Research and Innovation Agency (ID), Taipei Medical University (TW), Sultan Zainal Abidin University (MY), Padjadjaran University (ID), Hasanuddin University (ID)
Openalex Percentile: Top 69%
Tryptophan and brain disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.